Acute and sub-chronic toxicity study of methanol leaf extract of Cardiospermum halicacabum L and Vitex negundo L in rats


Pharmacognosy Communications,2015,5,1,39-45.
Type:Research Article

Acute and sub-chronic toxicity study of methanol leaf extract of Cardiospermum halicacabum L and Vitex negundo L in rats

Rajasekaran Aiyalu*, Arulkumaran Govindarajan and Arivukkarasu Ramasamy

KMCH College of Pharmacy Kovai Estate, Kalapatti Road Coimbatore , India


Introduction:Cardiospermum halicacabum L and Vitex negundo L are distributed throughout the plains of India and used in traditional practice for the treatment of inflammation and rheumatic disorders. The aim of this study is to evaluate acute and sub-chronic toxicity of methanol leaf extracts of Cardiospermum halicacabum (MLECH) and methanol leaf extract of Vitex negundo (MLEVN). MLECH and MLEVN were evaluated for acute and sub-chronic toxicity in mice and rats respectively. Materials and Methods: The acute oral toxicity study was carried out as per the OECD guidelines 423 and the sub-chronic toxicity was carried out as per the guidelines set by OECD 407 with slight modification. Body weight, food consumption, water consumption, hematological parameters, biochemical parameters, organ weight and histopathological analysis were carried out. Results: No sign of toxicity viz. lethargy, jerk, convulsion and mortality was observed upto 2000 mg/kg for MLECH and MLEVN in acute toxicity test. For sub-chronic toxicity test, single individual (400 mg/kg) and combined doses of MLECH and MLEVN (400 mg/kg each) in equal proportion not exhibited any signs of toxicity and mortality. Conclusion: In acute oral toxicity study, the oral administration of MLECH and MLEVN in mice was found to be safe up to a dose of 2000 mg/kg and in sub-chronic toxicity study no signs of toxicity observed at a dose of 400 mg/kg in rats.

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.